1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 02 MARCH 2015

World Generic Markets 02 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Roche Most At Risk From Upcoming Biosimilar Oncology Market
Industry Brief - Merck Provides MPP With Paediatric Raltegravir Licence
Industry Brief - Sucampo/R-Tech Settlement Overcomes Par Unoprostone ANDA
Industry Brief - Sandoz Launches Telmisartan In US
Industry Brief - Cambrex Expands Iowa API Facility
Industry Trend Analysis - Patent Ruling Edges Pulmicort Respules Toward Lifecycle End
Industry Brief - Teva Launches Enoxaparin And Linezolid Products In US
Industry Brief - Apotex' Second Biosimilar Application Accepted By FDA
Industry Brief - Actavis Gains US Buprenorphine Approval
Industry Brief - TWi To Sell Megestrol And Lidocaine Products In US
Industry Brief - Glenmark Launches Trandolapril+Verapamil In US
Industry Brief - Hospira Launches Inflectra In Remaining European Countries
Industry Brief - Use Of Biosimilar Infliximab Could Produce Significant CD Savings
Industry Brief - Acino Gains German Rivastigmine Court Victory
Industry Brief - Actavis To Divest Pharmatech To TPG
Industry Trend Analysis - Actavis' Future Dominated By Brands, But Generics Remain Important
Industry Brief - Actavis To Adopt Allergan Name
Industry Brief - Lupin And Celon Enter Fluticasone+Salmeterol Agreement
Industry Trend Analysis - Complex Sofosbuvir Relationship Favours Mylan
Industry Brief - Teva Commences USD1bn Debt Tender Offer

Table Of Contents

World Generic Markets 02 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.